Tags: efavirenz | cholesterol | HIV | Alzheimers
OPINION

HIV Drug Lowers Brain Cholesterol

Dr. Small By Thursday, 28 September 2017 04:27 PM EDT Current | Bio | Archive

Researchers at Case Western Reserve University have found that low doses of efavirenz, a drug used to treat AIDS, can improve the brain’s ability to clear cholesterol.

Although the experiments were performed in laboratory animals, the findings suggest that efavirenz could help treat or prevent Alzheimer’s in humans.

The drug binds to a brain enzyme that causes the breakdown of 80 percent of the brain’s cholesterol.

Efavirenz dosing is important for its cholesterol effect because high doses actually inhibit the enzyme and increase cholesterol levels.

The animal studies showed that the drug was able to remove 40 percent of the cholesterol from a mouse brain.

The observation that only small doses are needed for this effect suggests that if the medicine turns out to be effective in humans, side effects might be relatively mild.

© 2024 NewsmaxHealth. All rights reserved.


Dr-Small
Researchers at Case Western Reserve University have found that low doses of efavirenz, a drug used to treat AIDS, can improve the brain’s ability to clear cholesterol.
efavirenz, cholesterol, HIV, Alzheimers
134
2017-27-28
Thursday, 28 September 2017 04:27 PM
Newsmax Media, Inc.

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

(Optional for Local News)
Privacy: We never share your email address.
Join the Newsmax Community
Read and Post Comments
Please review Community Guidelines before posting a comment.
 
Find Your Condition
Get Newsmax Text Alerts
TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved
NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved